HOME >> BIOLOGY >> NEWS
Life In Womb Determines Adult Health

How Babies Are Ushered Into Life Determines How Healthily They Will Live As Adults, Book By Cornell Pregnancy Researcher Says

ITHACA, N.Y. -- Presenting the case that a lifetime of poor health -- from coronary artery disease and stroke to obesity and diabetes -- can start with poor conditions in the womb, Cornell University researcher and author Peter W. Nathanielsz, M.D., Ph.D., imagines three futuristic scenarios resulting from publication of his latest book, Life in the Womb: The Origin of Health and Disease (Promethean Press, 1999), which argues that adults may eventually suffer diseases of the heart, liver, pancreas and kidneys because those organs were incompletely formed during vulnerable periods of development in the womb:

-- Pregnant women will be encouraged to take better care of themselves and their unborn children by avoiding nicotine, alcohol and other drugs. Policy-makers and society at large will bolster the health of future generations by ensuring adequate prenatal care, removing undue stress about economic issues and providing better nutrition for women of child-bearing age.

-- Health insurers will require applicants to divulge their birth weight and hospitals will be required to record the weight of placentas.

-- Tort lawyers might develop a new legal specialty, encouraging children to sue their mothers for "sub-optimal" conditions in the womb.

Nathanielsz hopes that tort lawyers will ignore his book. But the Cornell professor of reproductive medicine wouldn't mind if pregnant women, policy-makers in government, the insurance industry and the general public heed the message from what, he says, is an emerging scientific consensus about "fetal programming" -- an ounce of prevention is worth a pound of cure.

According to the fetal programming theory (See "Ten Principles of Programming," attached.) , the developing fetus responds to nutritional and oxygen shortages by diverting precious resources to
'"/>

Contact: Roger Segelken
hrs2@cornell.edu
607-255-9736
Cornell University News Service
16-Jan-1999


Page: 1 2 3 4

Related biology news :

1. "Salt Gene" Determines Benefit Of Low-Salt Diet
2. Adult alcoholism and attention-deficit hyperactivity disorder are connected
3. Adult mouse bone marrow stem cells can become cells of the nervous system
4. Straight talk: Adult and embryonic stem cells and the future of research
5. Study: Adults maintain significant improvement in ADHD with long-term use of amphetamine
6. Adult stem cells shown to develop into all brain cell types
7. Adult stem cells selectively delivered into the eye and used to control angiogenesis at TSRI
8. U of Minnesota study: Adult bone marrow stem cells can become liver cells
9. Adult human breast stem cell candidate found
10. Adult bone marrow stem cells can become blood vessels
11. Adult stem cell therapy for heart failure proves promising

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Life Womb Determines Adult Health

(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... YORK , June 30, 2015 To bolster ... security provider HYPR Corp. announced today the addition of two ... will serve as board advisor and David Raviv ... the team underscore HYPR Corp.,s commitment to providing the most ... Dimitri Sirota co-founded Layer 7 Technologies, a provider ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: